Amanote Research
Register
Sign In
The Discovery of a Potent, Selective, and Peripherally Restricted Pan-TRK Inhibitor (PF-06273340) for the Treatment of Pain
doi 10.1021/acs.jmedchem.6b00850.s002
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Discovery of WAY-260022, a Potent and Selective Inhibitor of the Norepinephrine Transporter
ACS Medicinal Chemistry Letters
Organic Chemistry
Biochemistry
Drug Discovery
Discovery of GNF-5837, a Selective TRK Inhibitor With Efficacy in Rodent Cancer Tumor Models
ACS Medicinal Chemistry Letters
Organic Chemistry
Biochemistry
Drug Discovery
Selective TRK Inhibitor CH7057288 Against TRK Fusion-Driven Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
A Novel, Highly Potent and Selective Phosphodiesterase-9 Inhibitor for the Treatment of Sickle Cell Disease
Haematologica
Hematology
Discovery of Vibegron: A Potent and Selective 3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder
Discovery and Characterization of Verinurad, a Potent and Specific Inhibitor of URAT1 for the Treatment of Hyperuricemia and Gout
Scientific Reports
Multidisciplinary
Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable Γ-Secretase Inhibitor
ACS Medicinal Chemistry Letters
Organic Chemistry
Biochemistry
Drug Discovery
Discovery of a Selective Inhibitor of Oncogenic B-Raf Kinase With Potent Antimelanoma Activity
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Discovery of Zanubrutinib (BGB-3111), a Novel, Potent and Selective Covalent Inhibitor of Brutons Tyrosine Kinase
